Group items tagged

A pioneering study looking into the possibility of combining existing therapies to slow down cancer growth is showing encouraging early results. Elly Earls reports. A first-of-its-kind medical study at The Care Oncology Clinic on Harley Street, London, has started work on evaluating whether the use of a combination of safe, tolerable, existing, generic therapies could slow down cancer growth and improve survival times in patients for whom other treatments are no longer available or working.

Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.

US-based developer of new immunotherapeutics, including a portfolio of checkpoint modulators, anti-cancer vaccines and adjuvants, Agenus has completed the acquisition of Switzerland-based biopharmaceutical firm 4-Antibody.

Monographie von RIZOL (Trioxolan): Eine neue Sauerstoff-Verbindung; Eigenschaften, Pr�fmethoden, Identit�tspr�fung, Substanzbeschreibung sowie Hinweise auf Pr�fvorschriften und Literatur.

Personal Writings of Jim Humble related to use of the MMS products.    

Rooibos tea or red tea is grown in South Africa and has traditionally been used in the country as a potent medicine for numerous ailments. Apart from all its other health benefits, it is known to do wonders for the skin.